Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
Your new post is loading...
Your new post is loading...
BigField GEG Tech's curator insight,
December 9, 2013 5:29 AM
An original use of a transposon to better understand the hepatocarcinoma mechanisms.
|
|
The authors show that the CRISPR/Cas9 system can specifically target and cleave conserved regions in the HBV genome, resulting in robust suppression of viral gene expression and replication.
www.geg-tech.com/Vectors